Wasn't Tony Abbot at the reopening of the Boronia plant - to make more Relenza? And hasn't there been an extra production line opened somewhere in the US? And probably others that I can't remember of the top of my head.
Has Amex been feeding us a fairy story or not?
I am still inclined to believe all this - it certainly makes commercial sense. GSK's forward estimates don't seem to cover this potential production, but are they just a cover up to reduce the potential payout in the court case? I am certainly confused. Has anybody got a source in or near GSK?
R
BTA Price at posting:
0.0¢ Sentiment: None Disclosure: Held